Jerusalem Pharmaceuticals Stock: price and insider trades · Palestine
1 insider bought shares over the last 90 days, the latest by محمد محمود يوسف مسروجي, filed 14 Oct 2026.
Jerusalem Pharmaceuticals: what insiders have been doing
Jerusalem Pharmaceuticals is a listed company. Its insiders report their share dealings to PCMA / Palestine Exchange. From 15 November 2025 to 15 November 2026, the disclosure feed for Jerusalem Pharmaceuticals logged 11 filings by 4 insiders.
Only purchases show up on the open market, 11 purchases in all, filed by 4 insiders. No amount is published for 11 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 board members, 1 senior executive and 1 chief executive.
For context, the typical company on the same exchange (median of 51 companies) published 9 filings over the same period, against 11 filings here. Since 2018, the database holds 28 purchases and 1 sale by insiders of the company.
The most recent open-market purchase was published on 14 October 2026, 34 days ago.
This summary is built from PCMA / Palestine Exchange disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
· cache
T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.
- 6,203 sharesSharePEXPEX:4c2e348cfe2d-1Canonical exit: 12 Jan 2027 (T+90)
- 5,100 sharesSharePEXPEX:ea144f1d02e5-1Canonical exit: 11 Jan 2027 (T+90)
- 233,334 sharesSharePEXPEX:c2b3e0012a4c-1Canonical exit: 1 Aug 2026 (T+90)
- 5,309 sharesSharePEXPEX:d3ad5f0e2786-1Canonical exit: 15 Jun 2026 (T+90)
- 5,000 sharesSharePEXPEX:935112518e9c-1Canonical exit: 13 Jun 2026 (T+90)
- 1,501 sharesSharePEXPEX:556cd4ed4b4d-1Canonical exit: 9 Jun 2026 (T+90)
- 470 sharesSharePEXPEX:3062d1f27a4a-1Canonical exit: 8 Jun 2026 (T+90)
- 8,629 sharesSharePEXPEX:a31796958804-1Canonical exit: 2 Jun 2026 (T+90)
- 1,991 sharesSharePEXPEX:b9ae719e8140-1Canonical exit: 31 May 2026 (T+90)
- 2,100 sharesSharePEXPEX:89013bda3348-1Canonical exit: 27 May 2026 (T+90)
- 2,179 sharesSharePEXPEX:760877067442-1Canonical exit: 23 Mar 2026 (T+90)
- 20,200 sharesSharePEXPEX:7f77e1dc85ba-1Canonical exit: 20 Jan 2026 (T+90)
- 20,000 sharesSharePEXPEX:b024297e6ca5-1
- 1,372 sharesSharePEXPEX:8ae9b4acc0b3-1Canonical exit: 24 Apr 2024 (T+90)
- 2,914 sharesSharePEXPEX:6daaeec14e1e-1Canonical exit: 23 Apr 2024 (T+90)
- 1,623 sharesSharePEXPEX:607f38590cf4-1Canonical exit: 30 Oct 2023 (T+90)
- 1,800 sharesSharePEXPEX:60689e63ae98-1Canonical exit: 2 Jul 2022 (T+90)
- 2,600 sharesSharePEXPEX:b77d110dd481-1Canonical exit: 21 Jun 2022 (T+90)
- 2,200 sharesSharePEXPEX:c111549bead0-1Canonical exit: 19 Apr 2022 (T+90)
- 6,477 sharesSharePEXPEX:2835602b6454-1Canonical exit: 12 Apr 2022 (T+90)
- 1,000 sharesSharePEXPEX:57896b9e7cfc-1Canonical exit: 16 Mar 2022 (T+90)
- 2,520 sharesSharePEXPEX:3bb4175ce711-1Canonical exit: 12 Dec 2021 (T+90)
- 1,500 sharesSharePEXPEX:3b9ea52de80a-1Canonical exit: 26 May 2021 (T+90)
- 16,972 sharesSharePEXPEX:0730c4862fb5-1Canonical exit: 21 Dec 2020 (T+90)
- 300 sharesSharePEXPEX:cd6570b64199-1Canonical exit: 5 Jan 2020 (T+90)
25 of 29 declarations
About Jerusalem Pharmaceuticals
Jerusalem Pharmaceuticals is a company engaged in the manufacturing and distribution of pharmaceutical products. It operates in the XPAE market.
Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.
The weekly insider digest, free
One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.